Cargando…
Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
INTRODUCTION: Neuromyelitis optica spectrum disorders (NMOSD) are rare neuroinflammatory demyelinating diseases of the CNS, mainly affecting optic nerves, spinal cord and brainstem regions. The diagnosis depends on clinical symptoms, MRI findings and the detection of autoantibodies against the water...
Autores principales: | Held, Friederike, Klein, Ana-Katharina, Berthele, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989551/ https://www.ncbi.nlm.nih.gov/pubmed/33777853 http://dx.doi.org/10.2147/ITT.S287652 |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021) -
What's new in neuromyelitis optica spectrum disorder treatment?
por: Chu, Yi-Ching, et al.
Publicado: (2022) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)